N/A
Completed N=35
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
Source: ClinicalTrials.gov NCT05764005 ↗Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Feasibility - Recruitment — 39 Participants
Summary
This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility - Recruitment |
39 | — |
| PRIMARY Feasibility - Uptake |
30 | — |
| PRIMARY Acceptability - Mean Satisfaction Scores |
3.53; 3.70; 3.30; 2.80; 3.40; 4.40 | — |
Eligibility Criteria
Patient Inclusion Criteria:
- 55 years old or older
- Men diagnosed with low-risk prostate cancer currently on active surveillance
- Men who identify having a primary care provider
- Access and ability to use the Internet
Patient Exclusion Criteria:
- Men who are unable to read and/or speak English
- Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss)
PCP Inclusion Criteria:
- Identified by patient on baseline survey as their PCP
Urologist and Clinic Staff Inclusion Criteria:
- Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses
Data sourced from ClinicalTrials.gov (NCT05764005). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.